Given that Ibr/Rap skewed CD8 and CD4 TILs towards a TEMRA phenotype, we analyzed gene expression profiles of expanded TILs using a custom panel of over 700 tumor- and immune-related genes on the NanoString nCounter PanCancer Immune profiling platform (NanoString Technologies Inc.). This evidence concerns the gene CD4 and neoplasm.